Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma

New England Journal of Medicine

Volumn 342, Issue 25, 2000, Pages 1871-1876

  Beuschlein, Felix ^a   Strasburger, Christian J ^b   Siegerstetter, Volker ^a   Moradpour, Darius ^a   Lichter, Peter ^c   Bidlingmaier, Martin ^b   Blum, Hubert E ^a   Reincke, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACROMEGALY; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; LYMPHOMA, FOLLICULAR; MIDDLE AGED; RECEPTORS, SOMATOTROPIN; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034702238     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200006223422504     Document Type: Article

References (39)

1. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly: clinical and biochemical features in 500 patients. Medicine (Baltimore) 1994;73:233-40.
2. Molitch ME. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 1992;21:597-614.
3. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M. Recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 1995;80:3395-402.
4. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 1988;9:357-73.
5. Melmed S, Ezrin C, Kovacs K, Goodman RS, Frohman LA. Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med 1995;312:9-17.
6. Ezzat S, Ezrin C, Yamashita S, Melmed S. Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor Cancer 1993;71:66-70.
7. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
8. Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. 9th ed. Philadelphia: W.B. Saunders, 1998:300.
9. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 1991;12:424-49.
10. Strasburger CJ, Wu Z, Pflaum CD, Dressendorfer RA. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J Clin Endocrinol Metab 1996; 81:2613-20.
11. Wu Z, Kirk SE, Strasburger CJ. Quantitative measurement of human placental growth hormone (GH-V) by the immunofunctional HGH assay and a pituitary (GH-N)-specific sandwich immunoassay. Endocr Soc 1998; 80:291. abstract.
12. Losa M, Wolfram G, Mojto J, et al. Presence of growth hormone-releasing hormone-like immunoreactivity in human tumors: characterization of immunological and biological properties. J Clin Endocrinol Metab 1990;70:62-8.
13. Shen XY, Holt RI, Miell JP, et al. Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors. J Clin Endocrinol Metab 1998;83:2532-8.
14. Kahan Z, Arencibia JM, Csernus VJ, et al. Expression of growth hormone releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J Clin Endocrinol Metab 1999;84:582-9.
15. Ross RJ, Esposito N, Shen XY, et al. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full length receptor and generates large amounts of binding protein. Mol Endocrinol 1997;11:265-73.
16. Cameron DP, Burger HG, DeKretzer DM, Can KJ, Best JB. On the presence of immunoreactive growth hormone in a bronchogenic carcinoma. Australas Ann Med 1969;18:143-6.
17. Sparagana M, Phillips G, Hoffman C, Kucera L. Ectopic growth hormone syndrome associated with lung cancer. Metabolism 1971;20:730-6.
18. Greenberg PB, Martin TJ, Beck C, Burger HG. Synthesis and release of human growth hormone from lung carcinoma in cell culture. Lancet 1972;1:350-2.
19. Kaganowicz A, Farkouh NH, Frantz AG, Blaustein AU. Ectopic human growth hormone in ovaries and breast cancer. J Clin Endocrinol Metab 1979;48:5-8.
20. Dabek FT. Bronchial carcinoid tumour with acromegaly in two patients. J Clin Endocrinol Metab 1974;38:329-33.
21. Leveston SA, McKeel DW Jr, Buckley PJ, et al. Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor. J Clin Endocrinol Metab 1981;53:682-9.
22. Kayano K, Takeo M, Morisue S, Yamamoto M, Mizuno Y, Meguro F. A case of human growth hormone (h-GH)-producing adenocarcinoma of the lung. Nippon Kyobu Geka Gakkai Zasshi 1995;43:538-42. (In Japanese.)
23. Clark R. The somatogenic hormones and insulin-like growth factor-I: stimulators of lymphopoiesis and immune function. Endocr Rev 1997;18: 157-79.
24. Auernhammer CJ, Strasburger CJ. Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol 1995; 133:635-45.
25. LeRoith D, Yanowski J, Kaldjian EP, et al. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 1996;137:1071-9.
26. Harvey S, Hull KL. Growth hormone: a paracrinc growth factor? Endocrine 1997;7:267-79.
27. Timsit J, Savino W, Safieh B, et al. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992;75:183-8.
28. Kelley KW, Brief S, Westly HJ, et al. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci U S A 1986;83:5663-7.
29. Li YM, Brunke DL, Dantzer R, Kelley KW. Pituitary epithelial cell implants reverse the accumulation of CD4-CD8-lymphocytes in thymus glands of aged rats. Endocrinology 1992;130:2703-9.
30. Leung DW, Spencer SA, Cachianes G, et al. Growth hormone receptor and serum binding protein: purification, cloning, and expression. Nature 1987;330:537-43.
31. Kiess W, Butenandt O. Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization. J Clin Endocrinol Metab 1985;60:740-6.
32. Weigent DA, Riley JE, Galin FS, LeBoeuf RD, Blalock JE. Detection of growth hormone and growth hormone-releasing hormone-related messenger RNA in rat leukocytes by the polymerase chain reaction. Proc Soc Exp Biol Med 1991;198:643-8.
33. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H. Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and effects of GH-releasing hormone and somatostatin. J Clin Endocrinol Metab 1994;79:1678-80.
34. Varma S, Sabharwal P, Sheridan JF, Malarkey WB. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J Clin Endocrinol Metab 1993;76:49-53.
35. Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 1988;2:2812-8.
36. Wu H, Devi R, Malarkey WB. Localization of growth hormone messenger ribonucleic acid in the human immune system - a Clinical Research Center study. J Clin Endocrinol Metab 1996;81:1278-82.
37. Odell WD. Endocrine/metabolic syndromes of cancer. Semin Oncol 1997;24:299-317
38. 111In-octreotide scintigraphy in oncology. Metabolism 1992;41:Suppl 2:83-6.
39. Lipp RW, Silly H, Ranner G, et al. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med 1995;36:13-8.